Exact Mass: 572.2798693999999

Exact Mass Matches: 572.2798693999999

Found 500 metabolites which its exact mass value is equals to given mass value 572.2798693999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ganoderic acid H

6-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

Ganoderic acid H is found in mushrooms. Ganoderic acid H is from Ganoderma lucidum (reishi From Ganoderma lucidum (reishi). Ganoderic acid H is found in mushrooms. Ganoderic acid H is a triterpenoid.

LysoPI(16:0/0:0)

[(2R)-3-(hexadecanoyloxy)-2-hydroxypropoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C25H49O12P (572.2961484)

LysoPI(16:0/0:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(16:0/0:0), in particular, consists of one chain of palmitic acid at the C-1 position.

Bioadykinin Fragment 1-5

2-({2-[({1-[1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidine-2-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-1-hydroxyethylidene}amino)-3-phenylpropanoate

C27H40N8O6 (572.3070660000001)

Met-enkephalinamide

Leu Glu Ala Ile Asn

C25H44N6O9 (572.3169614)

Asn Leu Glu Ala Ile

C25H44N6O9 (572.3169614)

1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone

NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone

C25H44N6O9 (572.3169614)

C31H40O10

NCGC00381227-01_C31H40O10_

C31H40O10 (572.2621340000001)

C31H40O10_(1S,2R,4S,9R,10R,14S,15S,17S)-9-(3-Furyl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0~2,4~.0~4,13~.0~5,10~]octadec-17-yl 2-methylpropanoate

NCGC00380937-01_C31H40O10_(1S,2R,4S,9R,10R,14S,15S,17S)-9-(3-Furyl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0~2,4~.0~4,13~.0~5,10~]octadec-17-yl 2-methylpropanoate

C31H40O10 (572.2621340000001)

1-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C25H49O12P (572.2961484)

GANODERIC ACID H

6-[16-(acetyloxy)-5-hydroxy-2,6,6,11,15-pentamethyl-9,12,17-trioxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

1-(furan-3-yl)-7,11,16-trihydroxy-8,13a-dimethyl-12-oxodecahydro-1H,4H,5aH,7H-8,11a,3b-(epipropane[1,1,3]triyl)oxireno[2,3:2,3]cyclopenta[1,2-h]oxocino[2,3-c]isochromen-9-yl 2-methylbutanoate

C31H40O10 (572.2621340000001)

LPI 16:0

1-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C25H49O12P (572.2961484)

MC-Val-Cit-PAB-OH

C28H40N6O7 (572.295833)

Atorvastatin methyl ester

C34H37FN2O5 (572.2686364)

5H-Cyclopropa[3,4]benz[1,2-e]azulen-5-one,9,9a-bis(benzoyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-

C34H36O8 (572.2410056)

7,10-dimethoxy-Baccatin III

C31H40O10 (572.2621340000001)

Tamsulosin EP Impurity A

C30H40N2O7S (572.255609)

Adipic acid,phthalic anhydride,trimethylolpropane,2-ethylhexanoic acid polymer

C28H44O12 (572.2832624)

Arenobufagin 3-hemisuberate

C32H44O9 (572.2985174)

Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl) Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate

C30H36N8O4 (572.2859376)

Linagliptin Impurity 05

C30H36N8O4 (572.2859376)

Dronedarone N-Oxide

C31H44N2O6S (572.2919924)

Met-enkephalinamide

2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-phenylpropanamido]-4-(methylsulfanyl)butanamide

C27H36N6O6S (572.2416916)

1-hexadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C25H49O12P (572.2961484)

CID 124202182

C28H36N12O2 (572.3084036)

Arg-Asn-Gln-Arg

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C28H45O10P (572.2750199999999)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] decanoate

C24H45O13P (572.259765)

[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tridecanoate

C24H45O13P (572.259765)

1-hexadecanoyl-sn-glycero-3-phospho-D-myo-inositol

C29H48O9S (572.3018878)

Bradykinin (1-5)

C27H40N8O6 (572.3070660000001)

Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE). Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).

LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

C23H43F3N6O7 (572.3145164)

LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

C23H43F3N6O7 (572.3145164)

SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.

[(1s,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-14-[(3-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-14-[(3-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl (2z)-2-methylbut-2-enoate

C32H44O9 (572.2985174)

14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C28H44O12 (572.2832624)

6-(acetyloxy)-7,11-bis[(acetyloxy)methyl]-5-hydroxy-3,11,14-trimethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl 2-methylbut-2-enoate

C31H40O10 (572.2621340000001)

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

C37H40N4O2 (572.31511)

3-[2-(2h-1,3-benzodioxol-5-yl)-4-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-(piperidine-1-carbonyl)cyclobutyl]-1-(piperidin-1-yl)prop-2-en-1-one

C34H40N2O6 (572.288622)

6-[7-(acetyloxy)-11-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

(2s,3s,4r,4as,4bs,5r,7r,8ar,9r,10as)-2,9-bis(acetyloxy)-7-ethenyl-3,5,8a-trihydroxy-1,1,4a,7-tetramethyl-8-oxo-octahydro-2h-phenanthren-4-yl benzoate

C31H40O10 (572.2621340000001)

{8,9,12-trihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-13-yl}methyl 2-aminobenzoate

C30H40N2O9 (572.273367)

(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4-(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-13-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4-(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-13-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C32H44O9 (572.2985174)

(1'r,3'r,6's,8'r,12'e,18'e,20'z,24'r,25's)-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-6'-yl acetate

(1'r,3'r,6's,8'r,12'e,18'e,20'z,24'r,25's)-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-6'-yl acetate

C31H40O10 (572.2621340000001)

ethyl 2-[(1s,3r,4s,7r,8s,9s,11s,14s,17r,22s,23r,26s)-22-hydroxy-4,9,11,19,19-pentamethyl-5,10,24-trioxo-2,6,18,25-tetraoxaheptacyclo[12.10.1.1¹,⁸.0³,⁷.0¹⁴,²³.0¹⁶,²⁰.0¹¹,²⁶]hexacos-16(20)-en-17-yl]acetate

ethyl 2-[(1s,3r,4s,7r,8s,9s,11s,14s,17r,22s,23r,26s)-22-hydroxy-4,9,11,19,19-pentamethyl-5,10,24-trioxo-2,6,18,25-tetraoxaheptacyclo[12.10.1.1¹,⁸.0³,⁷.0¹⁴,²³.0¹⁶,²⁰.0¹¹,²⁶]hexacos-16(20)-en-17-yl]acetate

C31H40O10 (572.2621340000001)

9-(furan-3-yl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O10 (572.2621340000001)

methyl 2-[(1s,3r,4s,5r,7s,8s,9r,12s,13s)-4,5-bis(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C31H40O10 (572.2621340000001)

(4ar,6s,7r,7as)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

(4ar,6s,7r,7as)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5r,6s)-4-(2,2-dimethoxyethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C31H40O10 (572.2621340000001)

{"Ingredient_id": "HBIN014080","Ingredient_name": "9-deacetyl-9-benzoyl-10-debenzoyltaxchinin a","Alias": "NA","Ingredient_formula": "C31H40O10","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1O)C(C)(C)O)OC(=O)C)O)OC(=O)C)C)OC(=O)C4=CC=CC=C4)O","Ingredient_weight": "572.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4729","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "138114046","DrugBank_id": "NA"}

methyl 2-[16,17-bis(acetyloxy)-14-(furan-3-yl)-12-hydroxy-2,4,4,15-tetramethyl-5-oxo-8-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-10-en-3-yl]acetate

C31H40O10 (572.2621340000001)

(2r,6s)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-2h-naphtho[2,1-b]pyran-6-yl acetate

C32H44O9 (572.2985174)

11,13-bis(acetyloxy)-3a,4,10-trihydroxy-2,5,8,8-tetramethyl-12-methylidene-9-oxo-1h,2h,3h,4h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O10 (572.2621340000001)

6-[11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

17'-(1-hydroxyethyl)-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-6'-yl acetate

C31H40O10 (572.2621340000001)

(1s,2r,4s,6r,7s,10s,11r,18r)-18-hydroxy-7,11-dimethyl-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

(1s,2r,4s,6r,7s,10s,11r,18r)-18-hydroxy-7,11-dimethyl-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

C32H44O7S (572.2807594000001)

(2z)-3-[(1r,2s,3s,4r)-2-(2h-1,3-benzodioxol-5-yl)-4-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-(piperidine-1-carbonyl)cyclobutyl]-1-(piperidin-1-yl)prop-2-en-1-one

C34H40N2O6 (572.288622)

3-{2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

C32H44O9 (572.2985174)

1-[(1s,2s,5r,6r)-2-(2h-1,3-benzodioxol-5-yl)-6-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-5-(piperidine-1-carbonyl)cyclohex-3-ene-1-carbonyl]piperidine

C34H40N2O6 (572.288622)

[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-7-(methoxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-4-yl]methyl (2s)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C28H44O12 (572.2832624)

(1s,2r,4s,9r,10r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,9r,10r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C31H40O10 (572.2621340000001)

10-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-en-1-yl)-2-(2,4,5-trihydroxyphenyl)pyrano[3,2-g]chromen-4-one

C35H40O7 (572.2773890000001)

6-hydroxy-2-methyl-5-oxo-6-{2,4,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl}hept-3-en-2-yl acetate

C32H44O9 (572.2985174)

(1r,3s,4s,5r,6r,8r,9r,11r,13r,14r,15s)-9,11-bis(acetyloxy)-13-hydroxy-3,8,12,12,15-pentamethyl-16-oxo-7,17-dioxatetracyclo[12.2.1.0¹,⁵.0⁶,⁸]heptadecan-4-yl benzoate

C31H40O10 (572.2621340000001)

methyl (1s,4ar,5r,7r,7ar)-4a-hydroxy-5-{[(2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4ar,5r,7r,7ar)-4a-hydroxy-5-{[(2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C27H40O13 (572.246879)

(6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

(1r,2s,6r,10s,11r,12s,13s,15r)-8-[(acetyloxy)methyl]-1,6-dihydroxy-4,12,15-trimethyl-12-{[(2-methylbutanoyl)oxy]methyl}-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl (2z)-2-methylbut-2-enoate

C32H44O9 (572.2985174)

(1'r,3'r,6's,8'r,12'z,17'r,20'z,24'r,25's)-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-6'-yl acetate

(1'r,3'r,6's,8'r,12'z,17'r,20'z,24'r,25's)-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-11',22'-dioxo-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraen-6'-yl acetate

C31H40O10 (572.2621340000001)

(1r,3s,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (1s,3r,5r,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)

(1s,2s,6s,7s,9r,11s,13r,14s,15r,16s,17r)-14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

(1s,2s,6s,7s,9r,11s,13r,14s,15r,16s,17r)-14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-3-one

C28H44O12 (572.2832624)

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

C37H40N4O2 (572.31511)

(1s,3r,5s,6s,7r,9r,10r,13r,14r,16s,18r,20r,22s,24s)-7,13-dihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-26-one

(1s,3r,5s,6s,7r,9r,10r,13r,14r,16s,18r,20r,22s,24s)-7,13-dihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-26-one

C31H40O10 (572.2621340000001)

bis[(1r,3r,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl] (2e)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)

[(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a,7-dihydroxy-7-(methoxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,5h,6h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C28H44O12 (572.2832624)

(1s,2r,4s,5r,6r,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl (2e)-3-phenylprop-2-enoate

C35H40O7 (572.2773890000001)

(6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-7-(acetyloxy)-11-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

(3r,5r)-2-[(1r,2s,3s,4s,5s)-2-(acetyloxy)-5-chloro-4-hydroxy-4-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}cyclohexyl]-6-ethoxy-5-hydroxy-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

C29H45ClO9 (572.275195)

1-[2-(2h-1,3-benzodioxol-5-yl)-6-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-5-(piperidine-1-carbonyl)cyclohex-3-ene-1-carbonyl]piperidine

C34H40N2O6 (572.288622)

(1r,3s,5s,8r,9s,11r,12r,17r,21r)-21-hydroxy-8,13,13-trimethyl-5-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-4-methylidene-15-oxo-14,18,19-trioxapentacyclo[10.7.2.0¹,⁹.0³,⁸.0¹⁷,²¹]henicosan-11-yl acetate

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-9-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-8-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-4-yl (2e)-2-methylbut-2-enoate

C28H44O12 (572.2832624)

(2s,6r)-6-[(1r,3r,3ar,5ar,6r,9as,11ar)-6-[(acetyloxy)methyl]-3-hydroxy-3a,6,9a,11a-tetramethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

6-[(3as,4s,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C32H44O9 (572.2985174)

(1s,3r,5r,6s)-8-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (1r,3s,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

(1s,3r,5r,6s)-8-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (1r,3s,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)

2-[(2r,3r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3,5-dihydroxy-2-methyl-7-oxo-3h,4h,9h-pyrano[2,3-e]isoindol-8-yl]-3-(1h-indol-3-yl)propanoic acid

C34H40N2O6 (572.288622)

18-hydroxy-7,11-dimethyl-6-(1-{5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

18-hydroxy-7,11-dimethyl-6-(1-{5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-14-one

(2e,6r)-6-[(1r,3ar,4s,5ar,6r,9as,11r,11ar)-11-(acetyloxy)-4-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C32H44O9 (572.2985174)

[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C31H44N2O8 (572.3097504)

14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-9-yl acetate

C31H40O10 (572.2621340000001)

(2r,3s,6r)-3-[(1s,2r,3br,5ar,9as,9br,10r,11as)-2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

(2r,3s,6r)-3-[(1s,2r,3br,5ar,9as,9br,10r,11as)-2,10-dihydroxy-3b,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate

C32H44O9 (572.2985174)

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,22s,23r)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-9-yl acetate

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,22s,23r)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-9-yl acetate

C31H40O10 (572.2621340000001)

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-(2-methoxy-2-oxoethyl)-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

C35H40O7 (572.2773890000001)